Fajar Surya Wisesa Tbk. vs Brigit Biofarmaka Teknologi Tbk. — how do they compare? Fajar Surya Wisesa Tbk. trades at Rp5,275 (market cap 16.99T), while Brigit Biofarmaka Teknologi Tbk. trades at Rp240 (market cap 166.01B, 324K 24h volume). The key difference: Fajar Surya Wisesa Tbk. is far larger — about 102.3× Brigit Biofarmaka Teknologi Tbk.'s market cap. Which is the better fit depends on your goals.
| FASW | OBAT | |
|---|---|---|
Market Cap | 16.99T | 166.01B |
Volume | — | 324K |
Lot | — | 3.24K |
Turnover | — | 77.68M |
Average Price | — | 239.75 |
Value | — | 77.68M |
Indicative Equilibrium Price | — | 240 |
Indicative Equilibrium Volume | — | 1 |
Trailing returns across standard periods
Latest headlines on both assets
PT Fajar Surya Wisesa Tbk (the Company) was established based on Notarial Deed No. 20 dated June 13, 1987 of Lenny Budiman, S.H., notary in Jakarta.
Read more on FASW →PT. Brigit Biofarmaka Teknologi Tbk. (the Company) was established based on Notarial Deed No. 103 dated December 14, 2015 of Yoerista Arya Megasari, S.H., M.Kn., Notary in Sukoharjo. The company starts production commercially in 2018.
Read more on OBAT →